Altogether, our results support RTP801 as a readout for hippocampal pathology in HD patients and highlight RTP801 downregulation as a promising therapeutic strategy to ameliorate inflammatory events and to prevent motor and cognitive deficits in Huntington’s disease. The gene discussed is DDIT4; the disease is juvenile Huntington disease.